The current status of heart failure diagnostic biomarkers

Zhang, Xi, Schulz, Benjamin L. and Punyadeera, Chamindie (2016) The current status of heart failure diagnostic biomarkers. Expert Review of Molecular Diagnostics, 16 4: 487-500. doi:10.1586/14737159.2016.1144474


Author Zhang, Xi
Schulz, Benjamin L.
Punyadeera, Chamindie
Title The current status of heart failure diagnostic biomarkers
Journal name Expert Review of Molecular Diagnostics   Check publisher's open access policy
ISSN 1473-7159
1744-8352
Publication date 2016-01-01
Year available 2016
Sub-type Article (original research)
DOI 10.1586/14737159.2016.1144474
Open Access Status Not Open Access
Volume 16
Issue 4
Start page 487
End page 500
Total pages 14
Place of publication Abingdon, Oxfordshire, United Kingdom
Publisher Taylor & Francis
Language eng
Subject 2734 Pathology and Forensic Medicine
1313 Molecular Medicine
1312 Molecular Biology
1311 Genetics
Abstract Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the clinical manifestation of HF and will one day be integrated into a clinical workflow and facilitate HF management.
Formatted abstract
Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the clinical manifestation of HF and will one day be integrated into a clinical workflow and facilitate HF management.
Keyword Biomarker
Cardiovascular disease
Diagnostic
Heart Failure
Mass Spectrometry
saliva
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
School of Chemistry and Molecular Biosciences
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 2 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 22 Jan 2016, 19:51:03 EST by Mrs Louise Nimwegen on behalf of School of Chemistry & Molecular Biosciences